Cargando…

Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction

INTRODUCTION: Immune checkpoint inhibitors can lead to thyroid dysfunction. However, the understanding of the clinical phenotype of ICI-induced thyroid dysfunction in the real-world population is limited. The purpose of this study was to characterise the clinical patterns of dysfunction and evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsson-Brown, Anna, Lord, Rosemary, Sacco, Joseph, Wagg, Jonathan, Coles, Mark, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159260/ https://www.ncbi.nlm.nih.gov/pubmed/32163916 http://dx.doi.org/10.1530/EC-19-0473

Ejemplares similares

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
por: Cheung, Vincent Ting Fung, et al.
Publicado: (2020)

Su1185 IMMUNE CHECKPOINT INHIBITOR-RELATED COLITIS ASSESSMENT AND PROGNOSIS: CAN UCEIS, MAYO AND NANCY INDEX SCORING POINT THE WAY?
por: Cheung, Vincent T., et al.
Publicado: (2020)

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review
por: El Sabbagh, Rawaa, et al.
Publicado: (2020)

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles
por: Ye, Weiyu, et al.
Publicado: (2021)

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors
por: Kurimoto, Chiaki, et al.
Publicado: (2020)

Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction
por: Zhang, Qin, et al.
Publicado: (2023)

Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
por: Pariani, Nadia, et al.
Publicado: (2018)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients
por: Baek, Han-sang, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management
por: Zhan, Ling, et al.
Publicado: (2021)

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity
por: Hammond, Sean, et al.
Publicado: (2021)

Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022)

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
por: Grywalska, Ewelina, et al.
Publicado: (2018)

Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort
por: D’Aiello, Angelica, et al.
Publicado: (2021)

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022)

SAT-492 Impending Thyroid Storm Induced by Checkpoint Inhibitors
por: Zhou, Ya, et al.
Publicado: (2020)

Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2020)

Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
por: Shelly, Shahar, et al.
Publicado: (2020)

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
por: Chin, Ik Shin, et al.
Publicado: (2022)

Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?
por: Hammond, Sean, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
por: Maria Bignoli, Daniela Laura, et al.
Publicado: (2023)

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
por: Kasparian, Saro, et al.
Publicado: (2020)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

Warfarin: The End or the End of One Size Fits All Therapy?
por: Pirmohamed, Munir
Publicado: (2018)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis
por: Chen, Dennis H., et al.
Publicado: (2023)

Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach
por: Bollegala, Danushka, et al.
Publicado: (2018)

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Spillane, Susan, et al.
Publicado: (2020)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
por: Duan, Lian, et al.
Publicado: (2020)

Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer
por: Ponder, Michelle, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System
por: Lu, Difei, et al.
Publicado: (2022)

Two Types of Immune Checkpoint Inhibitor-related Pancreatitis
por: Ichiki, Tomoko, et al.
Publicado: (2021)

SAT-473 Thyroid Dysfunction in a Patient with Malignant Melanoma Treated with Immune Checkpoint Blockade
por: Gupta, Shaveta, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization
por: Urban, Hans, et al.
Publicado: (2022)

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
por: Ragusa, Francesca, et al.
Publicado: (2022)

Combining Mathematical Models With Experimentation to Drive Novel Mechanistic Insights Into Macrophage Function
por: Jansen, Joanneke E., et al.
Publicado: (2019)

Predicted limited redistribution of T cells to secondary lymphoid tissue correlates with increased risk of haematological malignancies in asplenic patients
por: Kmieciak, Aleksandra E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dp54sguhqmvufkbbiutdf3n527